(Q46246984)

20 December 2017

title

Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection (English)

1 reference

20 December 2017

1 reference

Katherine Samaras

1

1 reference

20 December 2017

Seng K Gan

2

1 reference

20 December 2017

Phillip W Peake

3

1 reference

20 December 2017

Andrew Carr

4

1 reference

20 December 2017

Lesley V Campbell

5

1 reference

20 December 2017

publication date

13 November 2008

1 reference

20 December 2017

published in

Obesity

1 reference

20 December 2017

volume

17

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

53-59

1 reference

20 December 2017

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Hypertriglyceridemia in the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Anti-retroviral therapy, insulin resistance and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Long-term body composition and metabolic changes in antiretroviral naive persons randomized to protease inhibitor-, nonnucleoside reverse transcriptase inhibitor-, or protease inhibitor plus nonnucleoside reverse transcriptase inhibitor-based strate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Clinical evaluation and management of metabolic and morphologic abnormalities associated with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Markers of mitochondrial biogenesis and metabolism are lower in overweight and obese insulin-resistant subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Increased cardiovascular disease risk indices in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Regulation of adiponectin in human immunodeficiency virus-infected patients: relationship to body composition and metabolic indices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Studies of adipose tissue metabolism in human immunodeficiency virus-associated lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Body shape changes in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Incidence of metabolic syndrome in a cohort of HIV-infected adults and prevalence relative to the US population (National Health and Nutrition Examination Survey)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2008.500

31 March 2020

Identifiers

DOI

10.1038/OBY.2008.500

1 reference

20 December 2017

1 reference

20 December 2017